NEW YORK LIFE INVESTMENT MANAGEMENT LLC 13D and 13G filings for IQ U.S. Mid Cap R&D Leaders ETF:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-10 1:46 pm Sale |
2023-12-29 | 13G | IQ U.S. Mid Cap R&D Leaders ETF MRND |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 0 0.000% |
-190,000 (Position Closed) |
Filing |
| 2022-06-10 1:09 pm Unchanged |
2022-05-31 | 13G | IQ U.S. Mid Cap R&D Leaders ETF MRND |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 190,000 95.000% |
0 (Unchanged) |
Filing |
| 2022-05-10 12:13 pm Unchanged |
2022-04-30 | 13G | IQ U.S. Mid Cap R&D Leaders ETF MRND |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 190,000 95.000% |
0 (Unchanged) |
Filing |
| 2022-04-08 3:08 pm Unchanged |
2022-03-31 | 13G | IQ U.S. Mid Cap R&D Leaders ETF MRND |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 190,000 95.000% |
0 (Unchanged) |
Filing |
| 2022-03-10 4:54 pm Purchase |
2022-02-28 | 13G | IQ U.S. Mid Cap R&D Leaders ETF MRND |
NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 190,000 95.000% |
190,000 (New Position) |
Filing |